Resumo: The CD-CORE project proposes an integrated approach to address the challenges of cancer diagnosis, side effects of therapies and optimisation of therapeutic strategies. This project is carried out by a multidisciplinary team from leading research institutions, integrating advanced technologies such as metabolomics, metagenomics, machine learning, and preclinical models. By focusing on key issues such as early cancer detection, toxicity prediction, and therapeutic optimization, the project aims to provide comprehensive solutions that will improve patient outcomes and reduce the healthcare burden. Through these innovative approaches, CD-CORE will contribute to the advancement of personalized cancer care, making a significant impact on both the scientific community and patient health outcomes.
Final beneficiaries/target audience: Cancer patients, healthcare systems, and the scientific community.
Timeline: April 2025 – March 2028
